Recent advances of cyclin-dependent kinases as potential therapeutic targets in HR+/HER2− metastatic breast cancer: a focus on ribociclib

Edessa D, Sisay M

Breast Cancer: Targets and Therapy 2017, 9:567-579

Published Date: 6 December 2017